TST001 in Patients With CLDN18.2 Positive Previously Treated Advanced Biliary Tract Cancer
Condition(s):Biliary Tract NeoplasmsLast Updated:July 27, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Biliary Tract NeoplasmsLast Updated:July 27, 2023Completed
Condition(s):Unresectable; Locally Advanced; MetastaticLast Updated:October 7, 2010Completed
Condition(s):Intrahepatic CholangiocarcinomaLast Updated:November 18, 2023Recruiting
Condition(s):Digestive CancerLast Updated:January 10, 2020Completed
Condition(s):Biliary Tract NeoplasmsLast Updated:February 13, 2018Completed
Condition(s):Biliary Tract CarcinomaLast Updated:August 9, 2021Unknown status
Condition(s):Biliary Tract NeoplasmsLast Updated:April 11, 2023Active, not recruiting
Condition(s):Biliary Tract Cancer (BTC)Last Updated:July 9, 2019Unknown status
Condition(s):Biliary Tract Carcinoma; Cholangiocarcinoma; Bile Duct CancerLast Updated:March 26, 2024Recruiting
Condition(s):Gastrointestinal CancerLast Updated:September 29, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.